文章及学术论文

我们致力于在所有专长领域内进行创新性研究。
您可以在下方查看我们已发表的文章，以进一步了解我们的研究及专长。

When Does “Access” Become “Established” in Rare Diseases?

When Does “Access” Become “Established” in Rare Diseases?

  • ISPOR 2021 EU
  • Jan 2023
Balancing Earlier Access and Data Immaturity – Are New Methods the Key?

Balancing Earlier Access and Data Immaturity – Are New Methods the Key?

  • ISPOR 2021 EU
  • Jan 2023
Costello Medical ISMPP EU Report 2022

Costello Medical ISMPP EU Report 2022

  • ISMPP 2022 EU
  • Nov 2022
Costello Medical ISPOR US Report 2021

Costello Medical ISPOR US Report 2021

  • ISPOR US 2021
  • Jul 2021
Costello Medical ISPOR Annual Meeting Report 2020

Costello Medical ISPOR Annual Meeting Report 2020

  • ISPOR US 2020
  • Jun 2020
Costello Medical ISMPP EU Report 2020

Costello Medical ISMPP EU Report 2020

  • ISMPP 2020 EU
  • Mar 2020
Trends in Patient-Focused Presentations at Scientific Congresses: A European Rheumatology Congress Case Study

Trends in Patient-Focused Presentations at Scientific Congresses: A European Rheumatology Congress Case Study

  • ISMPP 2020 EU
  • Mar 2020
Geographic Differences in the Growth of Open Access Publishing

Geographic Differences in the Growth of Open Access Publishing

  • ISMPP 2020 EU
  • Mar 2020
Costello Medical ISPOR Copenhagen Report 2019

Costello Medical ISPOR Copenhagen Report 2019

  • ISPOR 2019 Copenhagen
  • Dec 2019
Approaches to the Collection of Utility Values for Rare Diseases

Approaches to the Collection of Utility Values for Rare Diseases

  • ISPOR 2019 Copenhagen
  • Dec 2019
Impact of Generics and Biosimilars on Branded Drug Listing Decisions in Singapore

Impact of Generics and Biosimilars on Branded Drug Listing Decisions in Singapore

  • ISPOR 2019 Copenhagen
  • Dec 2019
Development, Validation and Concordance of Clinical Code Sets Used in Real-World Database Studies

Development, Validation and Concordance of Clinical Code Sets Used in Real-World Database Studies

  • ISPOR 2019 Copenhagen
  • Dec 2019
To What Extent Does Seeking Clinical Expert Opinion for Model Inputs Reduce the Cost of Uncertainty? A Conceptual Approach Using Expected Value of Perfect Parameter Information (EVPPI)

To What Extent Does Seeking Clinical Expert Opinion for Model Inputs Reduce the Cost of Uncertainty? A Conceptual Approach Using Expected Value of Perfect Parameter Information (EVPPI)

  • ISPOR 2019 Copenhagen
  • Dec 2019
Trust the Experts? Acceptance of Expert Elicitation in the National Institute for Health and Care Excellence (NICE) Single Technology Appraisal (STA) Process

Trust the Experts? Acceptance of Expert Elicitation in the National Institute for Health and Care Excellence (NICE) Single Technology Appraisal (STA) Process

  • ISPOR 2019 Copenhagen
  • Dec 2019
Parallel Scientific Advice from NICE and CADTH: Would One Submission Fit All?

Parallel Scientific Advice from NICE and CADTH: Would One Submission Fit All?

  • ISPOR 2019 Copenhagen
  • Dec 2019
Accurate Predictions of Life Year Gains for Immuno-Oncology Therapies in the Long Term? An Analysis Based on Published Checkmate 057 Nivolumab Data

Accurate Predictions of Life Year Gains for Immuno-Oncology Therapies in the Long Term? An Analysis Based on Published Checkmate 057 Nivolumab Data

  • ISPOR 2019 Copenhagen
  • Dec 2019
Real-World Evidence in Gene Therapies: Recommendations Versus Reality

Real-World Evidence in Gene Therapies: Recommendations Versus Reality

  • ISPOR 2019 Copenhagen
  • Dec 2019
A Formal System for Using Real-World Evidence to Revisit the HTA Decision: More Trouble Than It’s Worth?

A Formal System for Using Real-World Evidence to Revisit the HTA Decision: More Trouble Than It’s Worth?

  • ISPOR 2019 Copenhagen
  • Dec 2019
Is Delayed Access Due to Issues of HTA Capacity a Necessary Reality or an Unacceptable Problem?

Is Delayed Access Due to Issues of HTA Capacity a Necessary Reality or an Unacceptable Problem?

  • ISPOR 2019 Copenhagen
  • Dec 2019
Costello Medical ISMPP Asia-Pacific 2019 Report

Costello Medical ISMPP Asia-Pacific 2019 Report

  • ISMPP 2019 Asia-Pacific
  • Nov 2019
Costello Medical ISPOR US Report 2019

Costello Medical ISPOR US Report 2019

  • ISPOR 2019 New Orleans
  • Jul 2019
人类免疫缺陷病毒暴露前预防：应用中的管理考量及在中国的潜在价值

人类免疫缺陷病毒暴露前预防：应用中的管理考量及在中国的潜在价值

  • Online Article
  • Jun 2018
盐酸美金刚在中国治疗阿尔茨海默病的药物经济学模型

盐酸美金刚在中国治疗阿尔茨海默病的药物经济学模型

  • Online Article
  • Sep 2016
Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study

Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study

  • Online Article
  • Nov 2018
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study

Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study

  • Online Article
  • Aug 2018
难治性精神分裂症的研究进展

难治性精神分裂症的研究进展

  • Online Article
  • Mar 2018
基于索磷布韦的丙型肝炎治疗方案在中国的价值和应用潜力

基于索磷布韦的丙型肝炎治疗方案在中国的价值和应用潜力

  • Online Article
  • Mar 2018
直接抗病毒药物时代慢性丙型肝炎的治疗：不同方案选择的考虑

直接抗病毒药物时代慢性丙型肝炎的治疗：不同方案选择的考虑

  • Online Article
  • Oct 2018
丙型肝炎直接抗病毒疗法的药物相互作用

丙型肝炎直接抗病毒疗法的药物相互作用

  • Online Article
  • Oct 2018
Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan

Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan

  • Online Article
  • Oct 2018
Evidence Development Timeline of Medical Devices in the UK: Where do MedTech Innovation Briefings Fit?

Evidence Development Timeline of Medical Devices in the UK: Where do MedTech Innovation Briefings Fit?

  • ISPOR 2018 Barcelona
  • Nov 2018
Exploring the Use and Acceptance of Alternative Survival Modelling Approaches for Immuno-Oncology Therapies in UK Technology Assessments

Exploring the Use and Acceptance of Alternative Survival Modelling Approaches for Immuno-Oncology Therapies in UK Technology Assessments

  • ISPOR 2018 Barcelona
  • Nov 2018
Determining Factors for Decision-Making in the Medical Technologies Evaluation Programme

Determining Factors for Decision-Making in the Medical Technologies Evaluation Programme

  • ISPOR 2018 Barcelona
  • Nov 2018
Improving Patient and Financial Outcomes in the NHS: Early Arthritis Service Increases Patient Satisfaction Whilst Saving Costs

Improving Patient and Financial Outcomes in the NHS: Early Arthritis Service Increases Patient Satisfaction Whilst Saving Costs

  • ISPOR 2018 Barcelona
  • Nov 2018
Health Technology Assessment of mHealth Applications: Slow Progress in a Fast-Paced Industry?

Health Technology Assessment of mHealth Applications: Slow Progress in a Fast-Paced Industry?

  • ISPOR 2018 Barcelona
  • Nov 2018
Medical Device Appraisal in the UK: What Are the Common Pitfalls of Manufacturer Literature Reviews?

Medical Device Appraisal in the UK: What Are the Common Pitfalls of Manufacturer Literature Reviews?

  • ISPOR 2018 Barcelona
  • Nov 2018
Focused Ultrasound Thalamotomy and Other Interventions for Medication-Refractory Essential Tremor: An Indirect Comparison of Short-Term Impact on Health-Related Quality of Life

Focused Ultrasound Thalamotomy and Other Interventions for Medication-Refractory Essential Tremor: An Indirect Comparison of Short-Term Impact on Health-Related Quality of Life

  • Online Article
  • Jun 2018
Systematic Review of the Clinical Efficacy of Vaginal Progesterone for Luteal Phase Support in Assisted Reproductive Technology Cycles

Systematic Review of the Clinical Efficacy of Vaginal Progesterone for Luteal Phase Support in Assisted Reproductive Technology Cycles

  • Online Article
  • Jun 2018
Ask the Internet: Analysis of Online Discussions of Value Frameworks

Ask the Internet: Analysis of Online Discussions of Value Frameworks

  • HTAi 2017 Rome
  • Jun 2018
Hot Topics from the European Conference on Rare Diseases and Orphan Products 2018

Hot Topics from the European Conference on Rare Diseases and Orphan Products 2018

  • Published on LinkedIn
  • May 2018
Alkaptonuria Severity Score Index Revisited: Analysing the AKUSSI and Its Subcomponent Features

Alkaptonuria Severity Score Index Revisited: Analysing the AKUSSI and Its Subcomponent Features

  • Online Article
  • Apr 2018
Medical Affairs Leaders Forum 2018: Costello Medical’s Roundup

Medical Affairs Leaders Forum 2018: Costello Medical’s Roundup

  • Published on LinkedIn
  • Apr 2018
Release of First Medical Device HTA Guidance in Singapore

Release of First Medical Device HTA Guidance in Singapore

  • Published on LinkedIn
  • Apr 2018
Costello Medical’s Attendance at the Findacure Drug Repurposing for Rare Diseases Conference 2018

Costello Medical’s Attendance at the Findacure Drug Repurposing for Rare Diseases Conference 2018

  • Published on LinkedIn
  • Apr 2018
NICE Consultation on Proposed Changes to the Technology Appraisal Programme Phase 2

NICE Consultation on Proposed Changes to the Technology Appraisal Programme Phase 2

  • Feb 2018
Costello Medical’s Attendance at SMi’s Orphan Drugs and Rare Diseases Conference

Costello Medical’s Attendance at SMi’s Orphan Drugs and Rare Diseases Conference

  • Published on LinkedIn
  • Feb 2018
ISMPP European Meeting, London 2018

ISMPP European Meeting, London 2018

  • Feb 2018
Evidence in Support of Hyperkalaemia Management Strategies: A Systematic Literature Review

Evidence in Support of Hyperkalaemia Management Strategies: A Systematic Literature Review

  • Online Article
  • Feb 2018
Costello Medical’s MedTech Conference Roundup

Costello Medical’s MedTech Conference Roundup

  • Published on LinkedIn
  • Jan 2018
Buzzwords in Highly-Cited Manuscript Abstracts

Buzzwords in Highly-Cited Manuscript Abstracts

  • ISMPP 2018 London
  • Jan 2018
Rare Disease Publications: How Accessible Are They?

Rare Disease Publications: How Accessible Are They?

  • ISMPP 2018 London
  • Jan 2018
Reporting of Delphi Methods to Achieve Consensus on Guidelines in Rare Diseases

Reporting of Delphi Methods to Achieve Consensus on Guidelines in Rare Diseases

  • ISMPP 2018 London
  • Jan 2018
Long-Term Retention Rates for Anti-Epileptic Drugs: A Review of Long-Term Extension Studies and Comparison with Brivaracetam

Long-Term Retention Rates for Anti-Epileptic Drugs: A Review of Long-Term Extension Studies and Comparison with Brivaracetam

  • Online Article
  • Dec 2017
ISPOR 20th Annual European Congress, Glasgow 2017

ISPOR 20th Annual European Congress, Glasgow 2017

  • Dec 2017
Evaluating Matching-Adjusted Indirect Comparison and Simulated Treatment Comparison Techniques: Impact on HRQoL of Focussed Ultrasound Thalamotomy and Other Interventions for the Treatment of Medication-Refractory Essential Tremor

Evaluating Matching-Adjusted Indirect Comparison and Simulated Treatment Comparison Techniques: Impact on HRQoL of Focussed Ultrasound Thalamotomy and Other Interventions for the Treatment of Medication-Refractory Essential Tremor

  • ISPOR 2017 Glasgow
  • Nov 2017
No EQ-5D? Analysis of Alternative Utility Value Sources Used in NICE Appraisals for Oncology Indications

No EQ-5D? Analysis of Alternative Utility Value Sources Used in NICE Appraisals for Oncology Indications

  • ISPOR 2017 Glasgow
  • Nov 2017
Consumer Comments in Health Technology Assessment in Australia: How Common and Influential Are They?

Consumer Comments in Health Technology Assessment in Australia: How Common and Influential Are They?

  • ISPOR 2017 Glasgow
  • Nov 2017
Health Technology Assessment in Singapore: Shining a Light in the Darkness

Health Technology Assessment in Singapore: Shining a Light in the Darkness

  • ISPOR 2017 Glasgow
  • Nov 2017
How Do NICE Evidence Review Groups Perceive Single Technology Appraisals Presenting Limited Evidence of Comparative Treatment Efficacy?

How Do NICE Evidence Review Groups Perceive Single Technology Appraisals Presenting Limited Evidence of Comparative Treatment Efficacy?

  • ISPOR 2017 Glasgow
  • Nov 2017
When the Price Is Right: When, in Practice, Are Confidential Discounts Introduced in the NICE Process?

When the Price Is Right: When, in Practice, Are Confidential Discounts Introduced in the NICE Process?

  • ISPOR 2017 Glasgow
  • Nov 2017
An Audit of Evidence Review Group Criticisms of Systematic Literature Reviews Conducted to Inform Manufacturers’ Submissions to the National Institute for Health and Care Excellence

An Audit of Evidence Review Group Criticisms of Systematic Literature Reviews Conducted to Inform Manufacturers’ Submissions to the National Institute for Health and Care Excellence

  • ISPOR 2017 Glasgow
  • Nov 2017
Payers, Politics and Pandemonium: An Insight into the Future UK Pricing and Market Access Environment

Payers, Politics and Pandemonium: An Insight into the Future UK Pricing and Market Access Environment

  • ISPOR 2017 Glasgow
  • Nov 2017
Does the NICE Diagnostics Assessment Programme Use an Empirical ICER Threshold?

Does the NICE Diagnostics Assessment Programme Use an Empirical ICER Threshold?

  • ISPOR 2017 Glasgow
  • Nov 2017
Model Types Submitted to NICE: What Is Considered Appropriate by Evidence Review Groups?

Model Types Submitted to NICE: What Is Considered Appropriate by Evidence Review Groups?

  • ISPOR 2017 Glasgow
  • Nov 2017
An Exploration of the Methodology of Published Systematic Literature Reviews on “Burden of Disease”

An Exploration of the Methodology of Published Systematic Literature Reviews on “Burden of Disease”

  • ISPOR 2017 Glasgow
  • Nov 2017
Why do ‘True’ Orphan Medicines Have Such a Low Acceptance Rate When Assessed by the SMC?

Why do ‘True’ Orphan Medicines Have Such a Low Acceptance Rate When Assessed by the SMC?

  • ISPOR 2017 Glasgow
  • Nov 2017
Challenges Associated with Estimating Utility in Wet Age-Related Macular Degeneration: A Novel Regression Analysis to Capture the Bilateral Nature of the Disease

Challenges Associated with Estimating Utility in Wet Age-Related Macular Degeneration: A Novel Regression Analysis to Capture the Bilateral Nature of the Disease

  • Online Article
  • Oct 2017
Screening for Vasa Praevia in the Second Trimester of Pregnancy: External Review Against Programme Appraisal Criteria for the UK National Screening Committee (UK NSC)

Screening for Vasa Praevia in the Second Trimester of Pregnancy: External Review Against Programme Appraisal Criteria for the UK National Screening Committee (UK NSC)

  • Online Article
  • Jun 2017
Costs and Effectiveness of Fingolimod Versus Alemtuzumab in the Treatment of Highly Active Relapsing-Remitting Multiple Sclerosis in the UK: Re-Treatment, Discount, and Disutility

Costs and Effectiveness of Fingolimod Versus Alemtuzumab in the Treatment of Highly Active Relapsing-Remitting Multiple Sclerosis in the UK: Re-Treatment, Discount, and Disutility

  • Online Article
  • Jun 2017
HTAi 14th Annual Meeting, Rome 2017

HTAi 14th Annual Meeting, Rome 2017

  • Jun 2017
Inequity in Healthcare Access in Asian Countries with Reportedly High Universal Health Coverage Levels

Inequity in Healthcare Access in Asian Countries with Reportedly High Universal Health Coverage Levels

  • HTAi 2017 Rome
  • Jun 2017
Cost-Effectiveness of PET-CT Versus Adrenal Vein Sampling for the Diagnosis of Hypertension Caused by Primary Aldosteronism

Cost-Effectiveness of PET-CT Versus Adrenal Vein Sampling for the Diagnosis of Hypertension Caused by Primary Aldosteronism

  • HTAi 2017 Rome
  • Jun 2017
ISMPP 13th Annual International Meeting, Washington 2017

ISMPP 13th Annual International Meeting, Washington 2017

  • May 2017
NICE Annual Conference, London 2017

NICE Annual Conference, London 2017

  • May 2017
ISPOR 22nd Annual International Congress, Boston 2017

ISPOR 22nd Annual International Congress, Boston 2017

  • May 2017
Value Frameworks to Set Tongues Wagging: Analysis of Opinions and Discussions on Key Value Frameworks

Value Frameworks to Set Tongues Wagging: Analysis of Opinions and Discussions on Key Value Frameworks

  • ISPOR 2017 Boston
  • May 2017
Cost-Effectiveness of PET-CT Versus Adrenal Vein Sampling for the Diagnosis of Hypertension Caused by Primary Aldosteronism

Cost-Effectiveness of PET-CT Versus Adrenal Vein Sampling for the Diagnosis of Hypertension Caused by Primary Aldosteronism

  • ISPOR 2017 Boston
  • May 2017
Small and Medium-Sized Enterprises: How Do They Fare in the UK Medical Technologies Evaluation Programme (MTEP)?

Small and Medium-Sized Enterprises: How Do They Fare in the UK Medical Technologies Evaluation Programme (MTEP)?

  • ISPOR 2017 Boston
  • May 2017
Inequity in Healthcare Access in Asian Countries with Reportedly High Universal Health Coverage Levels

Inequity in Healthcare Access in Asian Countries with Reportedly High Universal Health Coverage Levels

  • ISPOR 2017 Boston
  • May 2017
Maximising Research Impact: Is Less More?

Maximising Research Impact: Is Less More?

  • ISMPP 2017 London
  • Jan 2017
ISMPP European Meeting, London 2017

ISMPP European Meeting, London 2017

  • Jan 2017
The Prevalence and Characteristics of Lay Summaries of Published Journal Articles

The Prevalence and Characteristics of Lay Summaries of Published Journal Articles

  • ISMPP 2017 London
  • Jan 2017
The Role of Scientific Interns as Medical Publication Professionals

The Role of Scientific Interns as Medical Publication Professionals

  • ISMPP 2017 London
  • Jan 2017
Using Augmented Reality for Congress Posters: Challenges and Considerations

Using Augmented Reality for Congress Posters: Challenges and Considerations

  • ISMPP 2017 London
  • Jan 2017
The Impact of Hepatitis C Virus Outside the Liver: Evidence from Asia

The Impact of Hepatitis C Virus Outside the Liver: Evidence from Asia

  • Online Article
  • Nov 2016
Risk of All-Cause Mortality in Alcohol-Dependent Individuals: A Systematic Literature Review and Meta-Analysis.

Risk of All-Cause Mortality in Alcohol-Dependent Individuals: A Systematic Literature Review and Meta-Analysis.

  • Online Article
  • Sep 2015
Loading